Advertisement

Topics

Abiomed Incorporated Company Profile

15:07 EST 22nd November 2017 | BioPortfolio

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES. The Company's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons, Abiomed is dedicated to providing the most advanced medical technologies to heart patients, with the ultimate goal of heart recovery and improved quality of life. Abiomed was founded more than two decades ago and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricle assist devices (VADs) than any other company in the world. The Company is focused on expanding its global distribution, fueling innovation and new products to broaden the Company's product portfolio to become the world's circulatory care leader. Key Facts: Year Founded: 1981 Corporate Headquarters: Danvers, Massachusetts European Division: Aachen, Germany Number of Employees: 300+ Product and Service Offerings: Heart Recovery and Assist: BVS 5000 Bi-ventricular Support System and AB5000 Circulatory Support System In Europe, Abiomed offers the IMPELLA® RECOVER® minimally invasive Cardiovascular Support Systems under CE mark approval Heart Replacement: the AbioCor Implantable Replacement Heart, and Under Development the AbioCor II

Location

33 Cherry Hill Drive
Danvers
01923
United States of America

Contact

Phone: 978 777 5410
Fax: 978 777 8411
Email: abmd@abiomed.com


News Articles [36 Associated News Articles listed on BioPortfolio]

Abiomed: Abiomed gibt Umsatz von 132,8 Millionen USD (Anstieg um 29 %) für das zweite Quartal des Geschäftsjahres 2018 und einen Rekord-Einsatz bei Patienten in den USA (Anstieg um 33 %) bekannt

DANVERS (USA), 27. Oktober 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (http://www.abiomed.com/) (NASDAQ:ABMD), ein führender Anbieter bahnbrechender Herzunterstützungstechnologien, vermeldete heute ei.....

Abiomed: Abiomed erhält PMA-Genehmigung der FDA für Impella RP® für Rechtsherzinsuffizienz

DANVERS, Massachusetts, den 22. September 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), ein führender Anbieter innovativer Technologien zur Unterstützung und Wiederherstellung der Herzfunk.....

Abiomed: Neue Studie mit Impella 2.5® Herzpumpe von Abiomed belegt nachweislich Überlebensvorteil beim prä-PCI-Einsatz der Pumpe bei Patienten mit Herzinfarkt der linken Hauptkoronararterie

DANVERS, Mass., July 3, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc (https://www.globenewswire.com/Tracker?data=zcP6Pp1wrZjuaxvGJzjaNnW122S7e70gBaoTheOmgfL3TqkF-whzZACCnCdGsrPjCL1OCRo5tMYqz6yPsJejyw==)....

Abiomed: Abiomed Receives FDA PMA Approval for Impella RP® for Right Heart Failure

DANVERS, Mass., 2017-09-21 00:26 CEST (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced it has received U....

Abiomed: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%

DANVERS, Mass., 2017-10-26 13:00 CEST (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2018 reven...

Abiomed: New Study with Abiomed's Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery

DANVERS, Mass., 2017-06-30 14:17 CEST (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publica...

Israeli medtech startup gets $15M boost from Abiomed, other investors

A round of Series B financing led by Abiomed and venture capital firm Pitango brought in $15 million for Israeli medical devi -More- 

Abiomed's Impella heart pump wins FDA nod for right heart failure

Abiomed obtained premarket approval from the FDA for its percutaneous temporary ventricular support device, the Impella RP Sy -More- 

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Biventricular Impella placement via complete venous access.

Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial access, Impella for ...

Companies [40 Associated Companies listed on BioPortfolio]

Abiomed Incorporated

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES. The Company's portfolio of heart support and recovery products and services offer healthcare profes...

Abiomed Inc.

Abiomed, Inc.

Medialink, Abiomed

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Abiomed Incorporated" on BioPortfolio

We have published hundreds of Abiomed Incorporated news stories on BioPortfolio along with dozens of Abiomed Incorporated Clinical Trials and PubMed Articles about Abiomed Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abiomed Incorporated Companies in our database. You can also find out about relevant Abiomed Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record